Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00395044Phase 2Completed
A Phase 2 trial of gabapentin in cannabis use disorder (CUD), sponsored by Scripps Research. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00395044.